Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
History
Social responsibility
Our companies
Debiopharm Group
Debiopharm S.A.
Debio R.P. S.A.
Debioclinic S.A.
Debiovision Inc.
Debioinnovation S.A.
Business Model
Strengths
Development capabilites
Preclinical
Clinical
Manufacturing
Regulatory
Innovative drug delivery and formulation
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Commercial Products
Eloxatin®
Decapeptyl®
News & Events
Press Releases
Awards
Publications
Conferences
News
02.09.2008
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate For Cancer Treatment
21.08.2008
Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology
Home
News & Events
Publications
Archives
Order
Date asc
Date desc
Title asc
Title desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Item Title
20-Oct-2005
Beneficial Effect of an Inhibitor of Leukocyte Elastase (EPI-hNE-4) in Presence of Repeated Lung Injuries
10-Nov-2004
Comparison of the oral delivery of three marketed Low Molecular Weight Heparins encapsulated in Nanoparticles
10-Nov-2004
A Novel Strategy for Determining the Amount of Protein Encapsulated in Polymeric Microparticles
14-Oct-2004
Functional Association of Cyclophilin with HCV Genome Replication
07-Jun-2004
Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres
13-Mar-2004
Cyclosporine A prodrug for topical delivery to the eye
24-Nov-2003
Phase IIa Clinical Study of a New Human Neutrophil Elastase Inhibitor, EPI-hNE4 (DX890), with repeated Administration by Inhalation in Adult CF Patients
06-Jul-2003
Characteristics of EPI-hNE4 Aerosol: A New Elastase Inhibitor for Treatment of Cystic Fibrosis
05-Jun-2003
The Psychopharmacology of Huperzine A: an Alkaloid with Cognitive Enhancing and Neuroprotective Properties of Interest in the Treatment of Alzheimer´s Disease
11-Mar-2003
Circulating Nerve Growth Factor Level Changes During Oxaliplatin Treatment-induced Neurotoxicity
14-Nov-2002
Interest of Insulin Nanoparticles for Oral Delivery in Diabetic Rats
04-Sep-2002
Poly (Epsilon Caprolactone)/Eudragit® RS Nanoparticles as a drug carrier for Oral Administration of Insulin in Diabetic Rats
13-May-2002
Protection against acute lung injury with EPI-hNE4
17-May-2001
Phase I Studies with a New Human Neutrophil Elastase Inhibitor, EPI-hNE4, administered by Inhalation in Healthy Volunteers
30-Dec-2000
PEG peptide and protein drug delivery - A procedure to identify the pegylation site.
< Prev
1
Next >
Results 1 - 15 of 15
Debio 025
( 28 items )
Triptorelin / Decapeptyl / Trelstar
( 7 items )
Oxaliplatin – Eloxatin – Elplat
( 12 items )
Debio 9902 - ZT-1
( 8 items )
Debio 8609 Sanvar
( 1 items )